NAT INST OF BIOLOGICAL SCIENCES BEIJING has a total of 11 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2013. It filed its patents most often in China, Republic of Korea and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are DAI DONGCHENG, IVASHCHENKO ALEKSANDR VASIL EVICH and YAMANOUCHI PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Republic of Korea | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Huang Niu | 6 |
#2 | Peng Shiming | 3 |
#3 | Lei Xiaoguang | 3 |
#4 | He Sudan | 3 |
#5 | Wang Yanli | 2 |
#6 | Zhang Zhiyuan | 2 |
#7 | Wang Xiaodong | 2 |
#8 | Ruan Hanying | 2 |
#9 | Qi Xiangbing | 2 |
#10 | Dong Ting | 2 |
Publication | Filing date | Title |
---|---|---|
CN111819288A | Immune signal amplification method based on hybrid chain reaction | |
WO2017152842A1 | Kinase inhibitors |